心血管精密医学 - 一个药物基因学视角
Sandosh Padmanabhan1, Clea du Toit1, Anna F Dominiczak1
1BHF Glasgow Cardiovascular Research Centre, School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
Cambridge prisms. Precision medicine
|March 29, 2024
概括
精准医学使用个体患者数据来定制治疗. 药物基因组学 (PGx) 是个性化心血管护理的关键,但其临床应用仍在发展.
科学领域:
- 药物基因组学 药物基因组学
- 心血管疾病 心血管疾病
- 精准医学是一门精准的医学.
背景情况:
- 目前的一种适合所有人的治疗方法仅对一半的患者有效.
- 精准医学整合了临床和生物数据,以实现个性化的诊断和治疗.
- 药物基因组学 (PGx) 是精准医学的一个关键组成部分.
研究的目的:
- 审查心血管疾病中药物基因组学的现状.
- 确定在临床实践中实施心血管PGx的关键推动因素和障碍.
主要方法:
- 关于心血管疾病中药物基因组学的文献综述.
- 对现有的药物基因组实施例进行分析.
- 确定促进或阻碍临床采用的因素.
主要成果:
- 几乎所有的个体都携带可操作的药物遗传变异.
- 50岁以上的成年人中有很大一部分正在服用已知与PGx相关的药物.
- 在心血管医学中PGx的应用仍在发展.
结论:
- 药物基因组学对个性化心血管医学具有重大潜力.
- 解决实施障碍对于广泛的临床采用至关重要.
- 需要进一步的研究和开发,才能充分实现心血管PGx的好处.
相关概念视频
Analysis of Population Pharmacokinetic Data
254
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
254
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Pharmacokinetic Models: Comparison and Selection Criterion
70
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
70
Pharmacokinetic Models: Overview
672
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
672
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
69
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
69
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.8K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K


